Zydus Lifesciences Limited has informed the Exchange regarding 'Public Announcement on Buyback'.
ZYDUSLIFE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Zydus Lifesciences Limited has announced a buyback of up to 95,65,217 equity shares (0.95% of total paid-up capital) at INR 1,150 per share. The total buyback size is INR 1,100 crore (INR 1,100 crores). The buyback price represents a premium of 23.88% on NSE and 23.33% on BSE over the volume weighted average market price. Record date is fixed as May 29, 2026, and the tender period will run from June 4, 2026 to June 10, 2026. The company states the buyback is aimed at distributing surplus cash to shareholders, optimizing returns and enhancing overall shareholder value. Promoter and promoter group hold approximately 75.46% of shares and may participate in the buyback.
The buyback at a 24% premium to market price is positive for shareholders as it offers an exit opportunity at attractive pricing. It signals management confidence in the company's financial health and is expected to support the stock price near-term.